Market Capitalization (Millions $) |
0 |
Shares
Outstanding (Millions) |
8 |
Employees |
16 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-7 |
Cash Flow (TTM) (Millions $) |
-4 |
Capital Exp. (TTM) (Millions $) |
0 |
Baudax Bio Inc
Baudax Bio Inc is a pharmaceutical company that focuses on developing and commercializing innovative pharmaceutical products for acute care settings. The company is committed to addressing important unmet medical needs and improving patient outcomes. Baudax Bio's flagship product is Anjeso, which is a non-opioid, long-acting NSAID (non-steroidal anti-inflammatory drug) for the management of moderate to severe pain. The company's mission is to advance the future of acute care therapeutics through the development of novel products that provide meaningful clinical benefit to patients and healthcare providers.
Company Address: 490 Lapp Road Malvern 19355 PA
Company Phone Number: 395-2440 Stock Exchange / Ticker: NASDAQ BXRX
|